Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
InSitu Biologics, Inc See All Filings	D	2025-12-18 16:36:05 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001723443-25-000003 Exclusions or Exemptions 506b Accepted Date 2025-12-18 16:36:05 UTC Type of Offering D Industry Biotechnology Principal Place of Business MINNESOTA Revenue or Assets Decline to Disclose Type of Security Equity
InSitu Biologics, Inc See All Filings	D	2023-12-29 11:09:14 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001790300-23-000004 Exclusions or Exemptions 506b Accepted Date 2023-12-29 11:09:14 UTC Type of Offering D Industry Biotechnology Principal Place of Business MINNESOTA Revenue or Assets Decline to Disclose Type of Security Debt
InSitu Biologics, Inc See All Filings	D	2021-02-24 18:16:15 UTC
Amount To Be Raised $5,500,000 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001790300-21-000002 Exclusions or Exemptions 506c Accepted Date 2021-02-24 18:16:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business MINNESOTA Revenue or Assets Decline to Disclose Type of Security Debt
Insitu Biologics, Inc. See All Filings	1-A POS	2019-03-27 08:16:42 UTC
Amount To Be Raised $7,333,376 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-19-001196 Accepted Date 2019-03-27 08:16:42 UTC Type of Offering 1-A POS Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A POS	2019-03-25 15:43:06 UTC
Amount To Be Raised $7,333,376 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-19-001151 Accepted Date 2019-03-25 15:43:06 UTC Type of Offering 1-A POS Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A POS	2019-01-04 06:55:22 UTC
Amount To Be Raised $10,000,009 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-19-000024 Accepted Date 2019-01-04 06:55:22 UTC Type of Offering 1-A POS Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A/A	2018-07-16 17:30:48 UTC
Amount To Be Raised $10,000,009 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-18-003545 Accepted Date 2018-07-16 17:30:48 UTC Type of Offering 1-A/A Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A/A	2018-07-11 15:56:09 UTC
Amount To Be Raised $10,000,009 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-18-003448 Accepted Date 2018-07-11 15:56:09 UTC Type of Offering 1-A/A Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A/A	2018-06-29 15:45:46 UTC
Amount To Be Raised $10,000,009 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-18-003280 Accepted Date 2018-06-29 15:45:46 UTC Type of Offering 1-A/A Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A/A	2018-06-21 21:03:01 UTC
Amount To Be Raised $10,000,009 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-18-003173 Accepted Date 2018-06-21 21:03:01 UTC Type of Offering 1-A/A Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Insitu Biologics, Inc. See All Filings	1-A	2018-06-04 20:41:41 UTC
Amount To Be Raised $10,000,009 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001477932-18-002887 Accepted Date 2018-06-04 20:41:41 UTC Type of Offering 1-A Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Offering Tier Tier2 Principal Place of Business MINNESOTA Revenue or Assets $0 State of Jurisdiction DELAWARE Type of Security E
InSitu Biologics, Inc See All Filings	D/A	2018-03-06 18:38:11 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001723443-18-000002 Exclusions or Exemptions 506c Accepted Date 2018-03-06 18:38:11 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MINNESOTA Revenue or Assets Decline to Disclose Type of Security Equity
InSitu Biologics, Inc See All Filings	D	2017-12-07 12:21:56 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001723443-17-000002 Exclusions or Exemptions 506c Accepted Date 2017-12-07 12:21:56 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MINNESOTA Revenue or Assets Decline to Disclose Type of Security Equity
InSitu Biologics, Inc See All Filings	D	2017-11-22 13:12:04 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001723443 Filed Document 0001723573-17-000002 Exclusions or Exemptions 506c Accepted Date 2017-11-22 13:12:04 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MINNESOTA Revenue or Assets Decline to Disclose Type of Security Equity